Trevi Therapeutics Inc (TRVI)

R&D Expense Growth

52.42%

Quarterly · Period ending:

TRVI logo

TRVI R&D Expense Growth

Latest reported52.42%
TRVI Quarterly R&D Growth (QoQ) (0.00% → 52.42%)
High-resolution chart · PNG

TRVI r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
52.4193%
60.5199%
-38.592%
7.4129%
20.2023%
-16.2629%
-16.8924%
12.0048%
13.8233%
35.0721%
3.084%
8.2335%
16.84%
15.8212%
-25.169%
13.0511%
9.8601%
-24.826%
30.9665%
-27.393%
16.2641%
-14.8018%
35.8741%
-1.8899%
-18.2422%
24.7978%
-14.6372%
2.2069%
65.6081%
-26.1994%
20.7099%
8.9561%
45.5353%
47.8723%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.